SMS Lifesciences India Ltd. (HALEOSLABS) Share Price Falls 9.21% to Rs 1,332

SMS Lifesciences India Ltd. traded at Rs 1,332, down 9.21% today, with a market capitalisation of Rs 439.6 crore.

SMS Lifesciences India Ltd. Share Price came under pressure on 11 August 2026, with the stock trading at Rs 1,332, down Rs 135.2 or 9.21% from the previous close of Rs 1,467.2. With a market capitalisation of Rs 439.6 crore, the company sits in the Micro Cap category, making today’s move notable in Stock Market Today screens tracking sharp single-day declines.

For investors searching SMS Lifesciences India Ltd. Share Price Today, the verified data confirms a clear price fall and places the stock among the top decliners identified by the workflow. The supplied data establishes what happened in price terms, but it does not establish a company-specific catalyst behind the decline. That distinction matters because intraday weakness, especially in smaller market-cap counters, can draw attention even when no confirmed corporate trigger is available in the dataset.

SMS Lifesciences India Ltd. Stock News is therefore being driven by market action rather than a stated event announcement in the supplied figures. Important metrics investors may monitor next include the stock’s valuation multiples, profitability ratios, relative standing within Pharmaceuticals & Drugs, and whether the current price action alters how the market reads the company’s financial profile. Univest notes that when a micro-cap name sees a sizeable same-day decline, the combination of price movement, low turnover and valuation context often becomes as important as any missing narrative around cause.

In that sense, SMS Lifesciences India Ltd. Share Price is trending today because the decline is large enough to qualify on a market-cap based screen, while the company’s Healthcare sector positioning and financial ratios give the move broader analytical relevance for investors following Share Market Today and Market News.

SMS Lifesciences India Ltd. (HALEOSLABS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,332
Previous Close	Rs 1,467.2
Today's Change	Rs -135.2 (-9.21%)
Day Open	Rs 1,332
Day High	Rs 1,332
Day Low	Rs 1,332
Current Volume (BSE)	3
BSE Traded Volume	3
NSE Traded Volume	58
Combined NSE + BSE Volume	61
Turnover	Rs 0 crore
Market Capitalisation	Rs 439.6 crore
Market Cap Category	Micro Cap

SMS Lifesciences India Ltd. (HALEOSLABS) traded at Rs 1,332. versus the previous close of Rs 1,467.2, a fall of 9.21%. The stock opened at Rs 1,332, reached Rs 1,332, touched Rs 1,332. Reported volume was 3.

SMS Lifesciences India Ltd. (HALEOSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 439.6 crore
P/E Ratio	28.07x
P/B Ratio	2.06x
ROE	11.07%
ROCE	12.96%
EPS	Rs 52.27
Dividend Yield	0.1%

SMS Lifesciences India Ltd. was valued at a P/E ratio of 28.07x, a P/B ratio of 2.06x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 11.07% and ROCE of 12.96%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 52.27, dividend yield of 0.1%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

SMS Lifesciences India Ltd. Share Price is drawing attention partly because the valuation and profitability profile is neither extremely stretched nor deeply distressed based on the supplied numbers. The company’s market capitalisation stands at Rs 439.6 crore, placing it well above the same-industry median market cap of Rs 146.99 crore, though below the industry average of Rs 500.01 crore. Market capitalisation shows company size, not quality, but it helps frame the stock within the listed Pharmaceuticals & Drugs universe.

The stock is trading at a P/E ratio of 28.07 and a P/B ratio of 2.06. On earnings valuation, the company’s P/E is above the industry median of 25.7 but well below the industry average of 69.27, which itself is influenced by a very wide range from 3.08 to 3,396.3 across 104 companies with available P/E data. On book value valuation, the company’s P/B of 2.06 is modestly above the benchmark median of 1.8 but below the benchmark average of 2.49 across 136 companies. That places the stock in a middle zone rather than at an obvious valuation extreme.

Profitability metrics are also fairly balanced. Return on equity is 11.07%, slightly above the benchmark median of 10.59% and above the benchmark average of 8.24. Return on capital employed is 12.96%, almost identical to the industry median of 12.98% but below the average of 15.72. This suggests the business is generating returns that are respectable versus the broader set, though not at the upper end of the group.

EPS stands at 52.27, which shows the earnings attributable to each share based on the supplied data. Dividend yield is 0.1, indicating a small historical/current payout relative to the current market price. Together with the P/E ratio, EPS helps frame why SMS Lifesciences India Ltd. Fundamental Analysis cannot be reduced to today’s price action alone. The stock’s financial profile appears measurable and profitable, even as today’s decline highlights market risk. Univest would therefore treat the current move as a market event first, with valuation and return ratios providing context rather than a verdict.

That leads naturally into a broader look at how the company sits within its sector and whether its numbers look stronger or weaker than the wider Healthcare and Pharmaceuticals & Drugs benchmark.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	28.07x
Benchmark Median P/E	25.7x
Benchmark Average P/E	69.27x
Benchmark P/E Range	3.08x to 3,396.3x
Company P/B Ratio	2.06x
Benchmark Median P/B	1.8x
Company ROE	11.07%
Benchmark Median ROE	10.59%
Company ROCE	12.96%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 439.6 crore
Benchmark Median Market Cap	Rs 146.99 crore

SMS Lifesciences India Ltd. (HALEOSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SMS Lifesciences India Ltd. (HALEOSLABS) has a P/E ratio of 28.07x, which is above the benchmark median of 25.7x, a difference of +9.22%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SMS Lifesciences India Ltd. (HALEOSLABS) has a ROE of 11.07%, which is above the benchmark median of 10.59%, a difference of +4.53%. SMS Lifesciences India Ltd. (HALEOSLABS) has a ROCE of 12.96%, which is below the benchmark median of 12.98%, a difference of -0.15%.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

SMS Lifesciences India Ltd. Share Price is best understood in the context of the Healthcare sector and the Pharmaceuticals & Drugs industry, where the supplied benchmark covers 137 companies in the same industry. The sector data shows a wide spread in valuation and profitability, which makes relative comparison more useful than judging the stock in isolation.

The company’s P/E ratio of 28.07 sits above the industry median of 25.7 but far below the industry average of 69.27. Because the benchmark range stretches from 3.08 to 3,396.3 across 104 companies, the average is likely skewed by outliers, so the median offers a steadier reference point. On that basis, SMS Lifesciences India Ltd. Share Price reflects an earnings multiple that is somewhat richer than the middle of the peer set, but not unusually high for the industry.

The P/B ratio of 2.06 compares with an industry median of 1.8 and an average of 2.49 across 136 companies. That places the stock slightly above the median on book-value valuation while still below the average. Profitability presents a similarly mixed picture. ROE at 11.07% is above both the median of 10.59% and the average of 8.24, which points to slightly better equity efficiency than much of the benchmark universe. ROCE at 12.96% is effectively in line with the median of 12.98% but below the average of 15.72, indicating capital returns that are close to typical for the group rather than exceptional.

Market-cap context is also relevant. At Rs 439.6 crore, the company is larger than the same-industry median of Rs 146.99 crore, though still below the average of Rs 500.01 crore and far below the maximum of Rs 3,032.97 crore. Univest reads this as a company with meaningful listed presence inside its niche, but not one that carries the balance-sheet scale of the bigger healthcare counters in the benchmark. That makes today’s market decline noteworthy, especially because investors comparing SMS Lifesciences India Ltd. Share Price with sector norms can see a business that sits around the middle of the pack on multiple financial measures.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	3,032.97	0	0.76	-2.89	-0.26
Hikal Ltd.	HIKAL	2,799.54	0	2.32	15.22	16.15
Kwality Pharmaceuticals Ltd.	KPL	2,707.2	40.09	9.77	28.21	26.35
Beta Drugs Ltd.	BETA	2,631.45	66.92	10.59	18.65	22.17
Panacea Biotec Ltd.	PANACEABIO	2,531.49	0	8.67	0	5.36

SMS Lifesciences India Ltd. (HALEOSLABS) has a P/E ratio of 28.07x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.07% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 12.96% versus the displayed peer median of 16.15%, providing a capital-efficiency comparison. SMS Lifesciences India Ltd. (HALEOSLABS) has a market capitalisation of Rs 439.6 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

SMS Lifesciences India Ltd. Share Price looks relatively compact in market-cap terms when set against the supplied peer set, where the listed comparables range from about Rs 2,057.85 crore to Rs 3,032.97 crore. At Rs 439.6 crore, SMS Lifesciences India Ltd. is materially smaller than peers such as Dishman Carbogen Amcis Ltd., Hikal Ltd., Kwality Pharmaceuticals Ltd., Beta Drugs Ltd. and Hester Biosciences Ltd. That smaller size can matter because price action in micro-cap names often behaves differently from larger listed peers.

On valuation, the company’s P/E ratio of 28.07 sits below Kwality Pharmaceuticals at 40.09, Beta Drugs at 66.92, NGL Fine-Chem at 44.48 and Sai Parenteral’s at 181.97, but above Venus Remedies at 17.49 and Hester Biosciences at 15.63. This suggests SMS Lifesciences India Ltd. Share Price is neither among the cheapest nor among the most expensive names on earnings among peers with available P/E data.

Its P/B ratio of 2.06 is above Dishman Carbogen Amcis at 0.76 and Solara Active Pharma Sciences at 1.93, but below Hikal at 2.32, Venus Remedies at 2.96, Sai Parenteral’s at 3.36, Hester Biosciences at 4.68, NGL Fine-Chem at 6.5, Panacea Biotec at 8.67, Kwality Pharmaceuticals at 9.77 and Beta Drugs at 10.59. In profitability terms, ROE of 11.07% is better than Dishman Carbogen Amcis at -2.89%, Panacea Biotec at 0 and Venus Remedies at 9.85%, but below Hikal at 15.22%, Hester Biosciences at 16.17%, Beta Drugs at 18.65%, NGL Fine-Chem at 27.9% and Kwality Pharmaceuticals at 28.21%.

ROCE of 12.96% is stronger than Dishman Carbogen Amcis at -0.26%, Panacea Biotec at 5.36% and Venus Remedies at 7.89%, roughly level with Sai Parenteral’s at 12.97%, but below Hikal at 16.15%, Solara at 15.34%, Hester Biosciences at 14.12%, Beta Drugs at 22.17%, Kwality Pharmaceuticals at 26.35% and NGL Fine-Chem at 33.91%. Univest therefore sees SMS Lifesciences India Ltd. Stock Analysis as showing middle-range valuation and profitability metrics inside a much larger peer group, even though today’s share price fall has pushed it into the list of Stocks in News.

Why Investors Are Watching SMS Lifesciences India Ltd.

SMS Lifesciences India Ltd. Share Price is being watched because a 9.21% single-day decline in a micro-cap healthcare stock is large enough to become a notable market event. Even without a verified company-specific catalyst in the supplied data, the combination of price fall, low turnover and middling valuation metrics makes the stock relevant for investors tracking Stocks Falling Today and Top Losers Today.

• Price action: The stock fell from Rs 1,467.2 to Rs 1,332, a drop of Rs 135.2 or 9.21%.
• Trading pattern: Open, high and low were all Rs 1,332 in the supplied snapshot, showing weakness was visible immediately.
• Volume profile: Total volume was 61 shares, with 3 on BSE and 58 on NSE, while turnover was Rs 0 crore.
• Fundamental context: P/E was 28.07, P/B 2.06, ROE 11.07% and ROCE 12.96%.
• Sector positioning: The company operates in Healthcare, specifically Pharmaceuticals & Drugs, across a same-industry benchmark of 137 companies.

What investors may monitor next is whether SMS Lifesciences India Ltd. Share Price continues to trade under pressure or stabilises around current levels, and how the stock’s valuation compares with peers if market sentiment remains weak. Univest also sees value in tracking whether the stock remains a short-term top decliner because low-liquidity counters can show outsized percentage moves without broad trading participation.

About SMS Lifesciences India Ltd.

SMS Lifesciences India Ltd. Share Price belongs to a company classified within the Healthcare sector and the Pharmaceuticals & Drugs industry. Based on the supplied company classification, this places the business within one of the core segments of the Indian stock market where listed companies are typically evaluated on product pipeline quality, manufacturing economics, profitability, valuation and return ratios.

Although the supplied dataset does not include a longer business description, the industry tagging itself is meaningful. Pharmaceuticals & Drugs companies are generally assessed by the market through a blend of earnings visibility, capital efficiency and balance-sheet quality. In the case of SMS Lifesciences India Ltd., investors following SMS Lifesciences India Ltd. Share Price Today are currently seeing a stock whose market capitalisation is Rs 439.6 crore and whose financial ratios place it around the middle of a broad same-industry benchmark.

The company’s current profile, based strictly on verified data, shows an earnings multiple of 28.07 times, a price-to-book ratio of 2.06, ROE of 11.07%, ROCE of 12.96%, EPS of 52.27 and dividend yield of 0.1. That combination indicates a listed pharmaceutical business with measurable profitability and a modest historical/current dividend payout, even though today’s trading session has turned attention toward short-term share price weakness. For readers looking at SMS Lifesciences India Ltd. Stock News and SMS Lifesciences India Ltd. Company News, the key takeaway is that the company sits in a recognised healthcare industry group and is being discussed today primarily because of market price action.

Track SMS Lifesciences India Ltd. Share Price on Univest

Use SMS Lifesciences India Ltd. (HALEOSLABS) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors who want to follow SMS Lifesciences India Ltd. Share Price more closely can use Univest to track live price updates, market capitalisation, valuation ratios, profitability metrics and broader market context in one place. Univest helps users monitor SMS Lifesciences India Ltd. Share Price Today alongside key data points such as P/E ratio, P/B ratio, ROE, ROCE, EPS, dividend yield, sector standing and 52-week level tracking when available.

Because smaller-cap stocks can move sharply on limited participation, a structured market dashboard becomes especially useful. On Univest, users can follow SMS Lifesciences India Ltd. Share Price Update, compare the stock with sector peers, review shareholding pattern data when reported, and track whether the stock remains among Market Movers or Stocks Under Pressure. That makes the platform useful for data-led monitoring without turning market information into a recommendation.

Frequently Asked Questions

What is the latest SMS Lifesciences India Ltd. Share Price today?

Ans. SMS Lifesciences India Ltd. Share Price Today was Rs 1,332 in the supplied market snapshot. The stock was down Rs 135.2 from the previous close of Rs 1,467.2, marking a 9.21% single-day decline.

Why is SMS Lifesciences India Ltd. Share Price falling today?

Ans. The supplied data confirms that SMS Lifesciences India Ltd. Share Price fell 9.21% today, but it does not identify a company-specific catalyst. The move is being tracked because it qualified on a market-cap based price-fall screen.

How much did SMS Lifesciences India Ltd. stock decline in today’s trade?

Ans. SMS Lifesciences India Ltd. stock declined by Rs 135.2 in today’s trade, falling from Rs 1,467.2 to Rs 1,332. In percentage terms, that equals a 9.21% drop, making it a notable top decliner today.

What does today’s intraday price action show for SMS Lifesciences India Ltd.?

Ans. The stock opened at Rs 1,332 and the supplied data also shows the day high and day low at Rs 1,332. That suggests the weakness was visible at the open, with no recorded rebound above that level.

What is the market capitalisation of SMS Lifesciences India Ltd.?

Ans. SMS Lifesciences India Ltd. had a market capitalisation of Rs 439.6 crore in the supplied data. That places the stock in the Micro Cap category, which helps explain why a 9.21% move attracts market-screen attention.

Is SMS Lifesciences India Ltd. expensive based on valuation metrics?

Ans. The stock traded at a P/E of 28.07 and a P/B of 2.06. Its P/E is above the industry median of 25.7, while its P/B is above the median of 1.8 but below the average of 2.49.

How profitable is SMS Lifesciences India Ltd. compared with its industry benchmark?

Ans. SMS Lifesciences India Ltd. reported ROE of 11.07% and ROCE of 12.96%. ROE is above the same-industry median of 10.59%, while ROCE is nearly identical to the benchmark median of 12.98% in Pharmaceuticals & Drugs.

What are the EPS and dividend yield of SMS Lifesciences India Ltd.?

Ans. The supplied data shows EPS of 52.27 and a dividend yield of 0.1 for SMS Lifesciences India Ltd. EPS reflects earnings attributable to each share, while dividend yield indicates the historical/current payout relative to market price.

Which sector and industry does SMS Lifesciences India Ltd. belong to?

Ans. SMS Lifesciences India Ltd. belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The benchmark used for comparison covers 137 same-industry companies, giving investors a broad reference for valuation and profitability analysis.

How does SMS Lifesciences India Ltd. compare with listed peers?

Ans. SMS Lifesciences India Ltd. is smaller than all supplied peers by market capitalisation at Rs 439.6 crore. Its P/E of 28.07 sits below names like Kwality Pharmaceuticals, Beta Drugs and Sai Parenteral’s, but above Venus Remedies and Hester Biosciences.